Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $3.22, but opened at $3.40. Curaleaf shares last traded at $3.27, with a volume of 12,003 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.

Curaleaf Price Performance

The firm has a market capitalization of $2.33 billion, a P/E ratio of -25.69 and a beta of 1.58. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56. The firm has a 50-day moving average of $2.83 and a 200-day moving average of $2.65.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.17. The business had revenue of $324.23 million for the quarter, compared to analysts’ expectations of $316.62 million. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%. As a group, analysts predict that Curaleaf Holdings, Inc. will post -0.12 EPS for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.